Intervention-Related Improvements in Adherence to Adjuvant Endocrine Therapy for Women 55+on Aromatase Inhibitors

被引：0
|
作者：
Jacobs, Jamie [1 ]
Massad, Katina [1 ]
Horick, Nora [1 ]
Cohn, Julia [1 ]
Walsh, Emily [1 ]
Rapoport, Chelsea [2 ]
Post, Kathryn [1 ]
Comander, Amy [1 ]
Antoni, Michael [3 ]
Safren, Steven [3 ]
Partridge, Ann [4 ]
Peppercorn, Jeffrey [1 ]
Park, Elyse [1 ]
Temel, Jennifer [1 ]
Greer, Joseph [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Univ Calif San Diego, La Jolla, CA 92093 USA
[3] Univ Miami, Coral Gables, FL 33124 USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
PSYCHO-ONCOLOGY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [41] SOCIAL NETWORK CHARACTERISTICS AND ADHERENCE TO ADJUVANT ENDOCRINE THERAPY IN BLACK AND WHITE WOMEN WITH BREAST CANCER
    Kroenke, Candyce
    Aoki, Rhonda
    Adams, Alyce
    Kennedy, David
    ANNALS OF BEHAVIORAL MEDICINE, 2022, 56 (SUPP 1) : S557 - S557
  • [42] Adjuvant endocrine therapy in premenopausal women - toxicities and adherence rates from a tertiary care centre
    Song, X.
    Graham, N.
    Dent, S. F.
    Hopkins, S.
    Verma, S.
    EJC SUPPLEMENTS, 2010, 8 (03): : 69 - 69
  • [43] Primary non-adherence to adjuvant endocrine therapy in older women with breast cancer.
    Tchuente, Vanina
    Stern, Donna
    Prchal, Jaroslav
    Martin, Judy
    Tamblyn, Robyn
    Meguerditchian, Ari N.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (27)
  • [44] The perspective of breast cancer women participating in an adherence-enhancing program for adjuvant endocrine therapy
    Turcotte, V
    Guillaumie, L.
    Lemay, M.
    Dionne, A.
    Lemieux, J.
    Provencher, L.
    Lauzier, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (01) : 281 - 281
  • [45] Changes in adjuvant endocrine therapy over one year among postmenopausal women with early-stage breast cancer initiating aromatase inhibitors.
    LaMorte, Danielle Lindsay
    Hartmann, Katherine E.
    Abramson, Vandana Gupta
    Mayer, Ingrid A.
    Peacock, Nancy Walker
    Cella, David
    Castel, Liana Desharnais
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [46] Incorporating the patient's voice in an intervention to promote adherence to adjuvant endocrine therapy for breast cancer survivors
    Jacobs, Jamie
    PSYCHO-ONCOLOGY, 2019, 28 : 45 - 45
  • [47] Bone health and adherence to vitamin D and calcium use in early breast cancer patients on endocrine therapy with aromatase inhibitors
    Vrdoljak, E.
    Soldic, Z.
    Boskovic, L.
    Jazvic, M.
    Dabelic, N.
    Mise, B. Petric
    Gugic, D.
    Radolovic, L. Bozac
    Zlatovic, J. Jovic
    Vazdar, L.
    Gasparic, M.
    Petkovic, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S95 - S95
  • [48] Prognostic and predictive value of TFF1 for adjuvant endocrine therapy in Chinese women with early ER positive breast cancer: Comparing aromatase inhibitors with tamoxifen
    Zhou, Liheng
    Yan, Tingting
    Jiang, Yiwei
    Di, Genhong
    Shen, Zhenzhou
    Shao, Zhimin
    Lu, Jinsong
    BREAST, 2011, 20 (01): : 15 - 20
  • [49] Adherence to adjuvant endocrine therapy for breast cancer: women's experiences of taking tamoxifen, letrozole and anastrozole
    Harrow, A.
    Dryden, R.
    McCowan, C.
    Radley, A.
    Parsons, M.
    Thompson, A. M.
    Wells, M.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2014, 18 : S12 - S13
  • [50] Improving outcomes for women diagnosed with early breast cancer through Adherence to adjuvant endocrine therapy (SWEET)
    Sharp, Linda
    Watson, Eila
    Wells, Mary
    Horne, Rob
    Hiller, Louise
    Todd, Adam
    Wolstenholme, Jane
    Fenlon, Deborah
    Cahir, Caitriona
    Brett, Jo
    Hughes, Lyndsay
    Wardley, Andrew
    Nicholson, Brian
    Donnelly, Peter
    Rose, Jan
    Turner, Lesley
    Dunn, Janet
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 544 - 545
12345